[go: up one dir, main page]

DK0825857T3 - Anvendelse af gabapentin og derivater deraf til behandling af mani og bipolær lidelse - Google Patents

Anvendelse af gabapentin og derivater deraf til behandling af mani og bipolær lidelse

Info

Publication number
DK0825857T3
DK0825857T3 DK96913852T DK96913852T DK0825857T3 DK 0825857 T3 DK0825857 T3 DK 0825857T3 DK 96913852 T DK96913852 T DK 96913852T DK 96913852 T DK96913852 T DK 96913852T DK 0825857 T3 DK0825857 T3 DK 0825857T3
Authority
DK
Denmark
Prior art keywords
treatment
mania
gabapentin
derivatives
bipolar disorder
Prior art date
Application number
DK96913852T
Other languages
Danish (da)
English (en)
Inventor
Atul Chandra Pande
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of DK0825857T3 publication Critical patent/DK0825857T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Beans For Foods Or Fodder (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Indole Compounds (AREA)
DK96913852T 1995-05-15 1996-04-26 Anvendelse af gabapentin og derivater deraf til behandling af mani og bipolær lidelse DK0825857T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/440,570 US5510381A (en) 1995-05-15 1995-05-15 Method of treatment of mania and bipolar disorder
PCT/US1996/005898 WO1996036328A1 (fr) 1995-05-15 1996-04-26 Methode de traitement de la manie et du trouble bipolaire

Publications (1)

Publication Number Publication Date
DK0825857T3 true DK0825857T3 (da) 2002-09-30

Family

ID=23749281

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96913852T DK0825857T3 (da) 1995-05-15 1996-04-26 Anvendelse af gabapentin og derivater deraf til behandling af mani og bipolær lidelse

Country Status (19)

Country Link
US (1) US5510381A (fr)
EP (1) EP0825857B1 (fr)
JP (1) JPH11505244A (fr)
AT (1) ATE218857T1 (fr)
AU (1) AU702435B2 (fr)
CA (1) CA2215923C (fr)
CZ (1) CZ288072B6 (fr)
DE (1) DE69621799T2 (fr)
DK (1) DK0825857T3 (fr)
EE (1) EE03420B1 (fr)
ES (1) ES2177783T3 (fr)
GE (1) GEP20002014B (fr)
HU (1) HUP9802087A3 (fr)
NO (1) NO315967B1 (fr)
NZ (1) NZ307366A (fr)
PT (1) PT825857E (fr)
SK (1) SK281982B6 (fr)
WO (1) WO1996036328A1 (fr)
ZA (1) ZA963826B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6372792B1 (en) 1996-04-26 2002-04-16 Guy Chouinard Method for treating anxiety, anxiety disorders and insomnia
ATE241351T1 (de) 1996-07-24 2003-06-15 Warner Lambert Co Isobutylgaba und dessen derivate zur schmerzbehandlung
AU9318398A (en) 1997-10-07 1999-04-27 Warner-Lambert Company Process for preparing a cyclic amino acid anticonvulsant compound
CN1303059C (zh) * 1997-10-27 2007-03-07 沃尼尔·朗伯公司 作为药物的环状氨基酸及其衍生物
KR100669280B1 (ko) * 1998-05-15 2007-01-17 워너-램버트 캄파니 엘엘씨 감마-아미노부티르산 유도체 포함 고상 조성물 및 그의제조 방법
CN1303991C (zh) 1998-05-15 2007-03-14 沃尼尔·朗伯公司 γ－氨基丁酸衍生物的稳定药物制剂和其制备方法
JP2002516312A (ja) 1998-05-26 2002-06-04 ワーナー−ランバート・カンパニー カルシウムチャンネルのα２δサブユニットに対する親和性を有する立体配座的に制約されたアミノ酸化合物
US6306910B1 (en) * 1998-07-09 2001-10-23 Warner-Lambert Company Use of Gaba-analogues for treating insomnia
KR100697734B1 (ko) * 1998-10-16 2007-03-22 워너-램버트 캄파니 엘엘씨 조증 및 양극성 장애 치료용 제약 조성물
DK1187832T3 (da) 1999-06-02 2003-03-10 Warner Lambert Co Aminoheterocycler, som er anvendelige som farmaceutiske midler
AP2002002501A0 (en) * 1999-10-07 2002-06-30 Warner Lambert Co Synergistic combinations of an NK1 receptor antagonist and a gaba structural analog.
PL363155A1 (en) * 2000-06-16 2004-11-15 Teva Pharmaceutical Industries, Ltd. Stable gabapentin having ph within a controlled range
NZ522480A (en) * 2000-06-26 2005-06-24 Warner Lambert Co Gabapentin analogues for sleep disorders
US20030119908A1 (en) * 2001-12-21 2003-06-26 Zambon Group S.P.A. Stable gabapentin compositions
ITMI20012750A1 (it) 2001-12-21 2003-06-21 Procos Spa Processo per la produzione dell'acido 1-(amminometil)-cicloesil-acetico in forma pura
CA2451267A1 (fr) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Utilisations pharmaceutiques de ligands alpha2delta
EP2575798B1 (fr) 2010-06-01 2017-08-09 Rubicon Research Private Limited Formes galéniques gastrorétentives d'analogues de gaba
WO2015144825A1 (fr) 2014-03-27 2015-10-01 Sanovel Ilac Sanayi Ve Ticaret A.S. Solution pharmaceutique liquide orale de gabapentine
US11670410B1 (en) * 2022-04-13 2023-06-06 Green Sky Creations LLC Systems and methods to automatically administer a psychoactive substance to an airway of a user based on a detected event or condition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087544A (en) * 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
DE2460891C2 (de) * 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US4355044A (en) * 1980-12-19 1982-10-19 Bernardo Heller D-Phenylalanine treatment
US5084479A (en) * 1990-01-02 1992-01-28 Warner-Lambert Company Novel methods for treating neurodegenerative diseases
US5086072A (en) * 1990-06-18 1992-02-04 The United States Of America As Represented By The Department Of Health And Human Services Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex
US5025035A (en) * 1990-10-12 1991-06-18 Warner-Lambert Company Method of treating depression

Also Published As

Publication number Publication date
NO975234L (no) 1997-11-14
HUP9802087A2 (hu) 1998-12-28
CZ355897A3 (cs) 1998-02-18
ATE218857T1 (de) 2002-06-15
WO1996036328A1 (fr) 1996-11-21
NO975234D0 (no) 1997-11-14
GEP20002014B (en) 2000-04-10
CA2215923A1 (fr) 1996-11-21
CA2215923C (fr) 2001-10-09
US5510381A (en) 1996-04-23
SK281982B6 (sk) 2001-09-11
NO315967B1 (no) 2003-11-24
AU5668996A (en) 1996-11-29
JPH11505244A (ja) 1999-05-18
PT825857E (pt) 2002-11-29
DE69621799D1 (de) 2002-07-18
SK152897A3 (en) 1999-05-07
MX9707269A (es) 1997-11-29
HUP9802087A3 (en) 1999-08-30
ZA963826B (en) 1996-11-21
AU702435B2 (en) 1999-02-18
EP0825857A1 (fr) 1998-03-04
EP0825857B1 (fr) 2002-06-12
CZ288072B6 (cs) 2001-04-11
DE69621799T2 (de) 2003-01-02
EE9700302A (et) 1998-06-15
ES2177783T3 (es) 2002-12-16
NZ307366A (en) 1999-10-28
EE03420B1 (et) 2001-06-15

Similar Documents

Publication Publication Date Title
DK0825857T3 (da) Anvendelse af gabapentin og derivater deraf til behandling af mani og bipolær lidelse
DE69203990D1 (de) Einrichtung zur transdermalen Verabreichung von Medikamenten.
NO20053106D0 (no) Oral, analgesisk doseringsform med forlenget frigivelse.
CA2344407A1 (fr) Traitement de la manie et des troubles bipolaires
ES2146886T3 (es) Inhibidores de la selectina de moleculas pequeñas bivalentes y trivalentes.
ATE234092T1 (de) 2-alkylpyrrolidine
YU48666B (sh) Mometason furoat monohidrat i postupak za njegovo dobijanje
DE69725860D1 (de) PLAN ZUR VERABREICHUNG VON H+, K+-ATPase INHIBITOREN
DE58901663D1 (de) I.m. injektionsformen von gyrase-inhibitoren.
ATE275966T1 (de) Activin stimulator enthaltende pharmazeutische zusammensetzung
FI955260L (fi) Transdermaalisia terapeuttisia systeemejä serotoniiniagonistien antamista varten
TR199802351T2 (xx) Topikal kullanım için bir veya birden fazla lokal anestezik ve anti-vajinit maddeler ihtiva eden anti-vajinit bileşimi.
BR9915460A (pt) Método de tratamento de febre hemorrágica virótica
YU42298A (sh) Upotreba olanzapina za pripremanje leka korisnog kod akutnog bola
BR0016941A (pt) Derivados de aminometil-fenil-ciclohexanona
ATE211383T1 (de) Topische aciclovir-zubereitung
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
ATE57526T1 (de) P-acylaminobenzamide.
NO981320L (no) Oral anvendelse av (+)-O-demetyltramadol som smertemiddel
SE9602262D0 (sv) New use of derivatives of cystine
ITRM930412A0 (it) Uso di acil l-carnitine gamma-idrossibutirrato per il trattamento di tossicodipendenze.
DE59712215D1 (de) Transdermales therapeutisches system mit einer östriol enthaltenden bisphosphatekombination
ES2139382T3 (es) Sistema terapeutico percutaneo para compuestos de silatran.
MX9801515A (es) Preparado de combinacion para la aplicacion en la demencia.
ATE77235T1 (de) I.m. injektionsformen von gyrase-inhibitoren.